Ultra-low-dose anti-VEGF treatment in retinopathy of prematurity

被引:1
作者
Sahin, Alparslan [1 ]
Sahin, Muhammed [2 ]
Turkcu, Fatih Mehmet [3 ]
机构
[1] Zilan Private Hosp, Dept Ophthalmol, TR-72060 Batman, Turkey
[2] Dicle Univ, Dept Ophthalmol, Sch Med, Diyarbakir, Turkey
[3] Bower Private Hosp, Dept Ophthalmol, Diyarbakir, Turkey
关键词
INTRAVITREAL BEVACIZUMAB;
D O I
10.1177/1120672119868428
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:NP290 / NP290
页数:1
相关论文
共 3 条
[1]   Efficacy of ultra-low-dose (0.1 mg) ranibizumab intravitreal injection for treatment of prethreshold type 1 retinopathy of prematurity: A case series [J].
Ahmed, Islam S. H. ;
Hadi, Ahmed M. A. ;
Hassan, Hassan H. .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (01) :40-47
[2]   Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy [J].
Mintz-Hittner, Helen A. ;
Geloneck, Megan M. ;
Chuang, Alice Z. .
OPHTHALMOLOGY, 2016, 123 (09) :1845-1855
[3]   Ultra-low dose of intravitreal bevacizumab in retinopathy of prematurity [J].
Sahin, A. ;
Gursel-Ozkurt, Z. ;
Sahin, M. ;
Turkcu, F. M. ;
Yildirim, A. ;
Yuksel, H. .
IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 (02) :417-421